Efficacy evaluation
The treatment efficacy was evaluated from three aspects, complete remission (CR), drug resistance, and relapse. CR was defined as normalization of β-hCG levels for at least three consecutive weeks. Relapse was defined as elevated serum β-hCG level after CR without any evidence of pregnancy. Drug-resistance was defined as serum β-hCG level decreasing >10% over two courses of chemotherapy.